China developing plans for strategic emerging industries, including biotechnology

12 August 2010

China will complete draft development plans for several strategic emerging industries by the end of September, said a person involved with the drafting of the plans reported by the China's 21st Century Business Herald.

The source told the business newspaper that the central government is currently busy drafting development plans for seven strategic emerging industries. These are: energy-saving and environmental protection; next generation information technology; bio-technology; high-end manufacturing; new energy; new materials and clean-energy vehicles.

The source said that after the primary plans have been drafted by the end of September, they will be presented to the relevant ministries and departments for feedback, before being submitted to China's highest authorities.

$1.5 billion to support drugs as part of plan

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >